The founder has a background in genomics and phenomics R&D and established UKBioLabs to address the need for more rigorous quality assurance in the peptide market. With operations now supporting the UK, Canada, and South Africa, the focus remains on providing consistently tested, high-quality peptides for research purposes.
We recognize the increasing scientific interest in amino acids and their role in human biology. While the human body contains more than 300 hundred thousand amino acid structures, only a fraction ( approx. 7K) have been thoroughly studied and characterized.
This highlights a rapidly expanding area of research, with growing attention on how these compounds may contribute to improved health, performance, and longevity.
